Home
Activity Overview
Related Articles
Poster: Shows Secukinumab Improves HS Symptoms and Psychiatric Comorbidities
Post-hoc analysis demonstrated secukinumab’s efficacy in addressing both HS and HS-related psychiatric symptoms.
Advancing Nail Disorder Care by Bridging Podiatry and Dermatology
At the 2024 SDPA Fall Conference, Tracey Vlahovic, DPM, highlighted the need for interdisciplinary collaboration in nail disorder management, underscoring the importance of mutual learning…
Doxycycline Postexposure Prophylaxis (DoxyPEP) for Bacterial STI Prevention
This Viewpoint describes what dermatologists should know about doxycycline postexposure prophylaxis (doxyPEP) for bacterial sexually transmitted infection (STI) prevention, specifically syphilis, chlamydia, and gonorrhea.
What Is the Scaly Erythematous Plaque on the Left Upper Cheek?
A 96-year-old woman presented to the dermatology clinic with a scaly plaque on her left cheek that had been there for many years.
Day 2 Recap: SDPA Fall 2024
Catch up on coverage from the second day of the 2024 Society of Dermatology Physician Associates Fall Conference in Las Vegas, Nevada.
From Clinic to Industry: Insights Into the MSL Role and PA Advocacy
At the 2024 SDPA Fall Conference, Sara Wilchowski, DMSc, MPAS, PA-C, highlighted the challenges and rewards of transitioning to industry roles, the impact of “Insta-Tok”…
Long-Term Risk of Autoimmune and Autoinflammatory Disorders After COVID-19
This cohort study investigates the long-term risk of autoimmune and autoinflammatory diseases among patients in South Korea who had a COVID-19 diagnosis using an extended…